|
|
||||||||
Genetics and Molecular Biology |
Center for Genomics Research, Karolinska Institute, Berzelius väg 37, 171 77, Stockholm, Sweden1
Center for Biomolecular Recognition, Panum Institute, Blegdamsvej 3c, DK 2200 Copenhagen N., and Pantheco A/S, Fruebjergvej 3, DK 2100 Copenhagen Ø., Denmark2
Author for correspondence: Liam Good. Tel: +46 8 728 6697. Fax: +46 8 323950. e-mail: liam.good{at}cgr.ki.se
Antisense peptide nucleic acids (PNAs) can inhibit Escherichia coli gene expression and cell growth through sequence-specific RNA binding, and this opens possibilities for novel anti-infective agents and tools for microbial functional genomics. However, the cellular effects of PNAs are limited relative to effects in cell extracts, presumably because of cell barrier components such as the outer-membrane lipopolysaccharide (LPS) layer or drug efflux pumps, both of which function to exclude antibiotics and other foreign molecules. To evaluate the importance of such cellular factors on PNA effects, the authors developed a positive assay for antisense inhibition by targeting the lac operon repressor and compared PNA susceptibilities in mutant and wild-type E. coli by assessing lacZ induction. Strains with defective LPS (AS19 and D22) were more permeable to the antibiotic nitrocefin and more susceptible to PNA than the wild-type. Also, PNA potency was improved in wild-type cells grown in the presence of certain cell-wall-permeabilizing agents. In contrast, the activities of the Acr and Emr drug efflux pumps were not found to affect PNA susceptibility. The results show that the LPS layer is a major barrier against cell entry, but PNAs that can enter E. coli are likely to remain active inside cells.
Keywords: peptide nucleic acid, bacteria, lipopolysaccharide
Abbreviations: CCCP, carbonyl cyanide m-chlorophenylhydrazone; PNA, peptide nucleic acid
This article has been cited by other articles:
![]() |
B. Jeon and Q. Zhang Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter J. Antimicrob. Chemother., May 1, 2009; 63(5): 946 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shi, A. R. Parker, L. Hua, C. N. Morrell, S. C. Lee, V. Bandaru, J. S. Dumler, T. C. Wu, and J. R. Eshleman Anti-gene padlocks eliminate Escherichia coli based on their genotype J. Antimicrob. Chemother., February 1, 2008; 61(2): 262 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Geller, J. Deere, L. Tilley, and P. L. Iversen Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis J. Antimicrob. Chemother., June 1, 2005; 55(6): 983 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Geller, J. D. Deere, D. A. Stein, A. D. Kroeker, H. M. Moulton, and P. L. Iversen Inhibition of Gene Expression in Escherichia coli by Antisense Phosphorodiamidate Morpholino Oligomers Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3233 - 3239. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sarno, H. Ha, N. Weinsetel, and M. E. Tolmasky Inhibition of Aminoglycoside 6'-N-Acetyltransferase Type Ib-Mediated Amikacin Resistance by Antisense Oligodeoxynucleotides Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3296 - 3304. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eriksson, P. E. Nielsen, and L. Good Cell Permeabilization and Uptake of Antisense Peptide-Peptide Nucleic Acid (PNA) into Escherichia coli J. Biol. Chem., February 22, 2002; 277(9): 7144 - 7147. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |